abstract |
The present invention relates to compounds of the formula I, wherein R1, R2, R3, R4, R5 and R6 are as defined in the specification and claims, the compounds are active in the GABAB receptor and are useful in the control or prevention of CNS diseases, especially diseases and disorders that include anxiety, depression, epilepsy, schizophrenia, and cognitive disorders. |